Venus Remedies has successfully launched Elores in Ecuador. This significant expansion follows the earlier launches of Elores in countries like Saudi Arabia, Myanmar, Oman, Tanzania, Ethiopia, and India, marking a momentous stride in the company's global growth. Additionally, the dossier has also been submitted in around 15 countries for getting the marketing authorisations.
Elores, a cutting-edge antibiotic formulation, has been developed to combat multi-drug-resistant infections, making it a ground breaking addition to Venus Remedies Limited's product portfolio. It is a novel patented Antibiotic Adjuvant Entity containing a beta-lactam antibiotic, a beta-lactamase inhibitor, and an Antibiotic Resistance Breaker (ARB) that work synergistically to rescue antibiotic activity and suppress the emergence of resistance against the antibiotic. With its proven efficacy against a wide range of bacteria, Elores is set to revolutionise the treatment of infections and enhance the quality of healthcare in Ecuador.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.20 |
Dr. Reddys Lab | 5820.00 |
Cipla | 1423.85 |
Zydus Lifesciences | 1008.15 |
Lupin | 1659.15 |
View more.. |